CEFADROXIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefadroxil, and what generic alternatives are available?
Cefadroxil is a drug marketed by Aurobindo Pharma, Chartwell Rx, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Ani Pharms, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy. and is included in twenty-three NDAs.
The generic ingredient in CEFADROXIL is cefadroxil/cefadroxil hemihydrate. Nineteen suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFADROXIL?
- What are the global sales for CEFADROXIL?
- What is Average Wholesale Price for CEFADROXIL?
Summary for CEFADROXIL
US Patents: | 0 |
Applicants: | 17 |
NDAs: | 23 |
Finished Product Suppliers / Packagers: | 19 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Clinical Trials: | 12 |
Patent Applications: | 5,810 |
Drug Prices: | Drug price information for CEFADROXIL |
DailyMed Link: | CEFADROXIL at DailyMed |
![CEFADROXIL drug patent expirations Drug patent expirations by year for CEFADROXIL](/p/graph/s/t/CEFADROXIL-patent-expirations.png)
![Drug Prices for CEFADROXIL](/p/graph/drug-price/CEFADROXIL.png)
Recent Clinical Trials for CEFADROXIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hasanuddin University | Phase 4 |
Rothman Institute Orthopaedics | Phase 3 |
University of Colorado, Denver | Phase 1 |
Pharmacology for CEFADROXIL
Drug Class | Cephalosporin Antibacterial |
US Patents and Regulatory Information for CEFADROXIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 065260-001 | Mar 30, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sun Pharm Inds Ltd | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 065115-001 | Mar 26, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ranbaxy | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 065018-001 | Apr 23, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sun Pharm Inds Ltd | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 065115-002 | Mar 26, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |